The Pulse of the Pharmaceutical Industry
Opiant Pharmaceuticals Inc. announced an agreement with Sanofi to manufacture Opiant’s investigational agent OPNTOO4 (drinabant) for the treatment of Acute Cannabinoid Overdose.
Read More »
Sorry. No data so far.
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.
August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!
© 2017 PharmaLive and Outcomes LLC